Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)

Clinical trial NCT01458600 · COMPLETED

Trial details

NCT number: NCT01458600
Sponsor: Mikael Lantz
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Graves´ Disease

Start date: 2006-09-01
Primary completion: 2016-02-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.